SIGA Technologies Inc. (NASDAQ: SIGA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SIGA TECHNOLOGIES INC.

SIGA Technologies Inc. (NASDAQ: SIGA)
Listen to this Section


$4.39
+0.0950 ( +2.21% ) 152.4K

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Clinical Trial Pipeline Stages


Drug Name Stage
TPOXX (Intravenous)DetailsSmallpox, Vaccine Approved
TPOXX® (tecovirimat)DetailsSmallpox Approved

Market Data


Open $4.39
Previous Close $4.29
Volume 152.4K
Market Cap $307.70M
Day Range $4.25 - $4.45
52 Week Range $4.10 - $9.62
Shares Outstanding 71.72M
Change % +2.21%
Net Change ▲ 0.0950
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryNone
IPO Year1997
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -413,694.00

Date Type Amount Purchased Purchaser
2024-07-03 Sale -32258.00 Hruby Dennis E
2024-07-03 Sale -24194.00 Luckshire Daniel J
2024-06-13 Sale -24712.00 DURNAN JAYMIE A
2024-06-13 Sale -24712.00 Varma Jay
2024-06-13 Sale -24712.00 Phillips Holly L.
2024-06-13 Sale -24712.00 Nemirovsky Julian
2024-06-13 Sale -24712.00 Nabel Gary J.
2024-06-13 Sale -24712.00 Marshall Joseph W III
2024-06-13 Sale -24712.00 Knisely Evan A.
2024-06-13 Sale -24712.00 Ford Harold Eugene Jr.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 11, 2025
4 Insider transactions 1 Jun 11, 2025
4 Insider transactions 1 Jun 11, 2025
4 Insider transactions 1 Jun 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy